相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Association between FGFR1 copy numbers, MAP3K1 mutations, and survival in axillary node-positive, hormone receptor-positive, and HER2-negative early breast cancer in the PACS04 and METABRIC studies
Dimitri Carene et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
POINT Circulating Tumor DNA for Modern Cancer Management
Ellen Heitzer
CLINICAL CHEMISTRY (2020)
Cell-free DNA analysis reveals POLR1D-mediated resistance to bevacizumab in colorectal cancer
Qing Zhou et al.
GENOME MEDICINE (2020)
Dynamics of breast-cancer relapse reveal late-recurring ER-positive genomic subgroups
Oscar M. Rueda et al.
NATURE (2019)
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER plus breast cancer
Luigi Formisano et al.
NATURE COMMUNICATIONS (2019)
FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast Cancer
Joshua Z. Drago et al.
CLINICAL CANCER RESEARCH (2019)
Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment
Christoph Suppan et al.
CANCERS (2019)
CNV Detection from Circulating Tumor DNA in Late Stage Non-Small Cell Lung Cancer Patients
Hao Peng et al.
GENES (2019)
Single tube liquid biopsy for advanced non-small cell lung cancer
Sanne de Wit et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Genomic alterations in plasma DNA from patients with metastasized prostate cancer receiving abiraterone or enzalutamide
Jelena Belic et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer
Daniel G. Stover et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis
Guoqiang Tan et al.
MEDICINE (2018)
Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma
S. Manier et al.
NATURE COMMUNICATIONS (2018)
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2018)
Change in HER2 status after neoadjuvant chemotherapy and the prognostic impact in patients with primary breast cancer
Atsushi Yoshida et al.
JOURNAL OF SURGICAL ONCOLOGY (2017)
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors
Viktor A. Adalsteinsson et al.
NATURE COMMUNICATIONS (2017)
Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy
Daniel H. Hovelson et al.
ONCOTARGET (2017)
Genomic Evolution of Breast Cancer Metastasis and Relapse
Lucy R. Yates et al.
CANCER CELL (2017)
rCGH: a comprehensive array-based genomic profile platform for precision medicine
Frederic Commo et al.
BIOINFORMATICS (2016)
Massively parallel DNA sequencing from routinely processed cytological smears
Laure Piqueret-Stephan et al.
CANCER CYTOPATHOLOGY (2016)
FGFR1 is an adverse outcome indicator for luminal A breast cancers
Yu-Jie Shi et al.
ONCOTARGET (2016)
Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancer
Peter Ulz et al.
NATURE COMMUNICATIONS (2016)
High-Level Clonal FGFR Amplification and Response to FGFR Inhibition in a Translational Clinical Trial
Alex Pearson et al.
CANCER DISCOVERY (2016)
Cross-laboratory validation of the OncoScan® FFPE Assay, a multiplex tool for whole genome tumour profiling
Joseph M. Foster et al.
BMC MEDICAL GENOMICS (2015)
Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach
Jelena Belic et al.
CLINICAL CHEMISTRY (2015)
Low Prognostic Implication of Fibroblast Growth Factor Family Activation in Triple-negative Breast Cancer Subsets
Hee Jin Lee et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Prognostic Value of FGFR Gene Amplification in Patients with Different Types of Cancer: A Systematic Review and Meta-Analysis
Jinjia Chang et al.
PLOS ONE (2014)
Changes in Colorectal Carcinoma Genomes under Anti-EGFR Therapy Identified by Whole-Genome Plasma DNA Sequencing
Sumitra Mohan et al.
PLOS GENETICS (2014)
Noninvasive Detection of HER2 Amplification with Plasma DNA Digital PCR
Heidrun Gevensleben et al.
CLINICAL CANCER RESEARCH (2013)
Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencing
Ellen Heitzer et al.
GENOME MEDICINE (2013)
Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer
Hans-Ulrich Schildhaus et al.
MODERN PATHOLOGY (2012)
FAST-SeqS: A Simple and Efficient Method for the Detection of Aneuploidy by Massively Parallel Sequencing
Isaac Kinde et al.
PLOS ONE (2012)
FGFR1 is amplified during the progression of in situ to invasive breast carcinoma
Min Hye Jang et al.
BREAST CANCER RESEARCH (2012)
FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer
Nicholas Turner et al.
CANCER RESEARCH (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
FGFR1 amplification in breast carcinomas: a chromogenic in situ hybridisation analysis
Somaia Elbauomy Elsheikh et al.
BREAST CANCER RESEARCH (2007)
Comprehensive profiling of 8p11-12 amplification in breast cancer
W Gelsi-Boyer et al.
MOLECULAR CANCER RESEARCH (2005)
分享论文
